mutLBSgeneDB

mutLBSgeneDB
mutated Ligand Binding Site gene DataBase

Home

Download

 Statistics

Help

About Us

Bioinformatics and Systems Medicine Laboratory Bioinformatics and Systems Medicine Laboratory

Gene Summary

Ligand Binding Site Mutation Information

Protein Structure Related Information

Gene Expression and Gene-Gene Network

Phenotype Information

Pharmacological Information

Conservation Information for LBS

Gene summary for ING1
Gene summary
Basic gene Info.Gene symbolING1
Gene nameinhibitor of growth family, member 1
Synonymsp24ING1c|p33|p33ING1|p33ING1b|p47|p47ING1a
CytomapUCSC genome browser: 13q34
Type of geneprotein-coding
RefGenesNM_001267728.1,
NM_005537.5,NM_198217.2,NM_198218.2,NM_198219.2,
Descriptiongrowth inhibitor ING1growth inhibitory protein ING1inhibitor of growth protein 1tumor suppressor ING1
Modification date20141207
dbXrefs MIM : 601566
HGNC : HGNC
Ensembl : ENSG00000153487
HPRD : 03337
Vega : OTTHUMG00000017346
ProteinUniProt: Q9UK53
go to UniProt's Cross Reference DB Table
ExpressionCleanEX: HS_ING1
BioGPS: 3621
PathwayNCI Pathway Interaction Database: ING1
KEGG: ING1
REACTOME: ING1
Pathway Commons: ING1
ContextiHOP: ING1
ligand binding site mutation search in PubMed: ING1
UCL Cancer Institute: ING1
Assigned class in mutLBSgeneDBB: This gene belongs to targetable_mutLBSgenes.

Gene ontology having evidence of Inferred from Direct Assay (IDA) from Entrez
GO IDGO TermPubMed ID


Top
Ligand binding site mutations for ING1
Lollipop-style diagram of mutations at LBS in amino-acid sequence.
We represented ligand binding site mutations only. (You can see big image via clicking.)
 
: non-synonymous mutation on LBS, Circle size denotes number of samples.

Cancer type specific mutLBS sorted by frequency
LBSAAchange of nsSNVCancer type# samples
W378W378RCOAD2
D370D370YCOAD1
E377E377KCOAD1
W378W378COV1
C358C358YSTAD1
D370D370YUCEC1
cf) Cancer type abbreviation. BLCA: Bladder urothelial carcinoma, BRCA: Breast invasive carcinoma, CESC: Cervical squamous cell carcinoma and endocervical adenocarcinoma, COAD: Colon adenocarcinoma, GBM: Glioblastoma multiforme, LGG: Brain lower grade glioma, HNSC: Head and neck squamous cell carcinoma, KICH: Kidney chromophobe, KIRC: Kidney renal clear cell carcinoma, KIRP: Kidney renal papillary cell carcinoma, LAML: Acute myeloid leukemia, LUAD: Lung adenocarcinoma, LUSC: Lung squamous cell carcinoma, OV: Ovarian serous cystadenocarcinoma, PAAD: Pancreatic adenocarcinoma, PRAD: Prostate adenocarcinoma, SKCM: Skin cutaneous melanoma, STAD: Stomach adenocarcinoma, THCA: Thyroid carcinoma, UCEC: Uterine corpus endometrial carcinoma.


Top
Protein structure related information for ING1
Relative protein structure stability change (ΔΔE) using Mupro 1.1
Mupro score denotes assessment of the effect of mutations on thermodynamic stability.
  (ΔΔE<0: mutation decreases stability, ΔΔE>0: mutation increases stability)
: nsSNV at non-LBS: nsSNV at LBS

nsSNVs sorted by the relative stability change of protein structure by each mutation
Blue: mutations of positive stability change. and red : the most recurrent mutation for this gene.
LBSAAchange of nsSNVRelative stability change
D370D370Y0.10766016
E377E377K-1.4667243
W378W378C-1.1993326
W378W378R-1.0898827
C358C358Y-0.7133892
(MuPro1.1: Jianlin Cheng et al., Prediction of Protein Stability Changes for Single-Site Mutations Using Support Vector Machines, PROTEINS: Structure, Function, and Bioinformatics. 2006, 62:1125-1132)

Structure image for ING1 from PDB
PDB IDPDB titlePDB structure
2QICCrystal Structure of the ING1 PHD Finger in complex with a Histone H3K4ME3 peptide

Top
Differential gene expression and gene-gene network for ING1
Differential gene expression between mutated and non-mutated LBS samples in all 16 major cancer types

Differential co-expressed gene network based on protein-protein interaction data (CePIN)
* Left PPI network was created from samples with mutations in the LBS of ING1 and the right PPI network was created from samples without mutations in the LBS of ING1. Only genes with p-value < 0.05 are shown.
Red circle: input gene. Orange circle: LBSgene. Blue circle: other gene.


Top

Top
Phenotype information for ING1
Gene level disease information (DisGeNet)
Disease IDDisease name# PubMedAssociation type
umls:C1168401Carcinoma, squamous cell of head and neck2Biomarker, GeneticVariation
umls:C0242656Disease Progression1Biomarker
umls:C0038356Stomach Neoplasms1Biomarker

Mutation level pathogenic information (ClinVar annotation)
Allele IDAA changeClinical significanceOriginPhenotype IDs

Top
Pharmacological information for ING1
Gene expression profile of anticancer drug treated cell-lines (CCLE)
Heatmap showing the correlation between gene expression and drug response across all the cell-lines. We chose the top 20 among 138 drugs.We used Pearson's correlation coefficient.
Drug information targeting mutLBSgene (Approved drugs only)
Drug statusDrugBank IDNameTypeDrug structure

Gene-centered ligand-gene interaction network

Ligands binding to mutated ligand binding site of ING1 go to BioLip
Ligand IDLigand short nameLigand long namePDB IDPDB namemutLBS


Top
Conservation information for LBS of ING1
Multiple alignments for Q9UK53 in multiple species
LBSAA sequence# speciesSpecies


Copyright © 2016-Present - The University of Texas Health Science Center at Houston
Site Policies | State of Texas